Grant: Engage Grants Program
Dalhousie University
$25,000.00
Chemoenzymatic methods to prepare N-glucuronides for use in drug discovery
EF 2016-17
Résumé
Humans metabolize drugs and other xenobiotics to reduce the xenobiotics activity and accelerate the rate ofexcretion from the human body. The aim of this proposal is to investigate methods to synthesizeN-glucuronides because these are increasingly identified xenobiotic metabolites, and there are a lack ofappropriate methods to prepare these analytical standards.Sussex Research Inc. is a for profit Canadian company that sells carbohydrates, glycans, and analytical servicesrelated to the chemical and pharmaceutical industry. One aspect of their portfolio is the need to be able tosupply metabolites of drugs/xenobiotics for drug metabolism and pharmacokinetic regulatory purposes. Theyhave a large variety of metabolites available through chemical synthesis, but lack appropriate N-glucuronides.They have been unable to synthesize these compounds using chemical approaches, despite extensive attemptsby their in-house research and development team. They have contacted Jakeman, an expert in chemoenzymaticsynthesis, in an effort to come up with new methods to synthesize these compounds. Jakeman has proposedtwo approaches that have the potential to solve this problem. The first is an engineered enzyme approach, andthe second the use of liver microsomes as catalysts. Over the duration of this Engage grant, proof-of-conceptstudies will take place to ascertain the feasibility of these approaches to deliver the desired compounds and newtechnical capabilities to Sussex Research Inc.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Nova Scotia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
492417-2015
Name nom
Jakeman, David
Department département
Pharmacy, College of
Organization id
79
Institution établissement
Dalhousie University
Province en
Nova Scotia
Province fr
Nouvelle-Écosse
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1551
Committee name en
Atlantic Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Atlantique
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3702
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Carbohydrates
Research subject fr
Glucides
Partie
1
Nb partie
1
Application title
Chemoenzymatic methods to prepare N-glucuronides for use in drug discovery
Keyword
NSERC
Application summary
Humans metabolize drugs and other xenobiotics to reduce the xenobiotics activity and accelerate the rate ofexcretion from the human body. The aim of this proposal is to investigate methods to synthesizeN-glucuronides because these are increasingly identified xenobiotic metabolites, and there are a lack ofappropriate methods to prepare these analytical standards.Sussex Research Inc. is a for profit Canadian company that sells carbohydrates, glycans, and analytical servicesrelated to the chemical and pharmaceutical industry. One aspect of their portfolio is the need to be able tosupply metabolites of drugs/xenobiotics for drug metabolism and pharmacokinetic regulatory purposes. Theyhave a large variety of metabolites available through chemical synthesis, but lack appropriate N-glucuronides.They have been unable to synthesize these compounds using chemical approaches, despite extensive attemptsby their in-house research and development team. They have contacted Jakeman, an expert in chemoenzymaticsynthesis, in an effort to come up with new methods to synthesize these compounds. Jakeman has proposedtwo approaches that have the potential to solve this problem. The first is an engineered enzyme approach, andthe second the use of liver microsomes as catalysts. Over the duration of this Engage grant, proof-of-conceptstudies will take place to ascertain the feasibility of these approaches to deliver the desired compounds and newtechnical capabilities to Sussex Research Inc.